Lactibiane Topic AD 125ml
Lactibiane Topic AD 125ml
173.00 SAR
Clinical Problem
Target Patient
Infants, children, and adults with atopic dermatitis
Steroid-sparing strategy for mild-moderate AD
Skin barrier reinforcement in eczema-prone patients
Patients with S. aureus-associated flares
Product Benefits
Skin Microbiome Restoration
Probiotic lysate technology directly modulates the skin microbiome — reducing S. aureus dominance and restoring commensal diversity.
Barrier Reinforcement
Ceramide and lipid-rich formulation restores barrier function. Reduces TEWL. Clinically measurable barrier improvement.
Immune Modulation
Probiotic lysate activates tolerogenic immune responses at the skin level — reducing Th2-driven inflammation without systemic effects.
Steroid-Sparing
Designed as a steroid-sparing adjunct — reducing frequency and potency of topical corticosteroid requirement.
Treatment Areas
Atopic dermatitis
Eczema
Dry/sensitive skin
Steroid-sparing adjunct
Barrier maintenance
Product Composition
| Probiotic Lysate (Lactobacillus) | Inactivated probiotic fragments · direct skin immune modulation · no live bacteria required |
| Emollient Base | Ceramide-rich · lipid-replenishing · barrier restoration |
| Preservative System | Paediatric-safe · hypoallergenic · tested for skin tolerance |
| Format | Cream 125ml · All ages · daily topical application |
Clinical Results
Probiotic
Lysate Technology
All Ages
Indication Range
WGO
Supported
HQM®
Certified
Steroid
Sparing Use
125ml
Pack Size
Treatment Protocol
Age Range
All Ages
Infants, children, adults
Application
1–2× Daily
Affected areas · thin layer
Duration
Ongoing
Daily maintenance · as needed during flares
Format
Topical Cream
125ml tube
Treatment Areas
Atopic dermatitis · Eczema · Dry/sensitive skin · Steroid-sparing adjunct · Barrier maintenance
Frequently Asked Questions
Probiotic lysate contains bacterial cell wall fragments that directly interact with pattern recognition receptors (PRRs) in the skin. This activates tolerogenic immune pathways — reducing Th2 inflammation without requiring live bacteria.
Scientific References
- Atopic dermatitis microbiome dysbiosis and probiotic lysate mechanisms · JID review
- Topical probiotic therapy in AD — systematic review and meta-analysis · British Journal of Dermatology
- WGO probiotic guide 2023 · topical probiotic application evidence summary
Duration
All clinical data referenced from published peer-reviewed sources. For professional use by qualified healthcare providers only. Not for patient self-diagnosis or treatment.

